LOGIN  |  REGISTER
C4 Therapeutics
Astria Therapeutics

Community Health Systems Improves Quality of Life in Local Communities With Doctors’ Day Donations and Third Annual Jars of Love Peanut Butter Drive

March 31, 2025 | Last Trade: US$2.40 0.05 -2.04
  • More than $260,000 donated to charitable organizations in honor of physicians
  • More than 100,000 peanut butter jars donated to community food banks

FRANKLIN, Tenn. / Mar 31, 2025 / Business Wire / Community Health Systems, Inc. (NYSE: CYH) (“CHS”) announced today that its affiliated hospitals have donated more than $260,000 to charitable organizations in their communities to address social determinants of health and improve quality of life in honor of Doctors’ Day, which was celebrated on Sunday, March 30.

The medical staff at each location selected organizations that address specific needs in the community such as food assistance, housing, children and youth programs, disaster relief and education.

National Doctors’ Day celebrates the dedication and compassion demonstrated by the more than one million physicians who provide healthcare to patients nationwide.

“For the third year in a row, we are recognizing the physicians in every community we serve by supporting organizations that improve the health and well-being of underserved individuals,” said Tim L. Hingtgen, Chief Executive Officer of Community Health Systems, Inc. “We are grateful for the skilled and compassionate care that these physicians provide across our organization. Our Doctors’ Day donations are a small way that we can show our appreciation and make a positive impact in their honor.”

CHS also collected more than 100,000 jars of peanut and other nut butters to donate to more than 60 food banks as part of its third annual Jars of Love Peanut Butter Drive. This enterprise-wide initiative to fight hunger was launched in 2023 because peanut butter, with its high nutritional value and long shelf life, is one of the most requested items by food banks. CHS-affiliated health systems and the corporate office collected jars at hospital facilities and at community locations throughout the month of March.

According to the U.S. Department of Agriculture, food insecurity is on the rise. In 2023, 47.4 million people, including almost 14 million children, lived in households experiencing food insecurity, an increase of 3.2 million over the previous year.

“Access to nutritious food is foundational to overall health. Jars of Love is one more way that we support our communities, raise awareness of the ongoing fight against hunger, and provide tangible support to the food banks that are feeding individuals in the communities we serve. I appreciate the great generosity of our employees, physicians, volunteers and community members who embraced this year’s effort,” said Hingtgen.

About Community Health Systems, Inc.

Community Health Systems, Inc. is one of the nation’s largest healthcare companies. The Company’s affiliates are leading providers of healthcare services, developing and operating healthcare delivery systems in 37 distinct markets across 15 states. The Company’s subsidiaries own or lease 73 affiliated hospitals with more than 10,000 beds and operate more than 1,000 sites of care, including physician practices, urgent care centers, freestanding emergency departments, occupational medicine clinics, imaging centers, cancer centers and ambulatory surgery centers.

The Company’s headquarters are located in Franklin, Tennessee, a suburb south of Nashville. Shares in Community Health Systems, Inc. are traded on the New York Stock Exchange under the symbol “CYH.” More information about the Company can be found on its website at www.chs.net.

Chimerix

Stock Quote

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page